These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8284920)

  • 1. [A comparative evaluation of the immunogenicity and reactogenicity of recombinant vaccines against hepatitis B].
    Gorbunov MA; Pavlova LI; Noslova AV; Ikoev VN; Bektimirov TA; Voĭtenkov MM; Belyshev BP; Borisenko IA; Titov IA
    Vopr Virusol; 1993; 38(5):216-8. PubMed ID: 8284920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunogenicity of the Heberbiovac-HB vaccine in children].
    Díaz González M; Chiang Macía A; Díaz Acosta D; Bravo González JR; Rodríguez Lay L; Pedroso Flaquet P; López-Chávez AU
    Rev Cubana Med Trop; 1996; 48(3):195-8. PubMed ID: 9805051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of recombinant vaccines against hepatitis B and the results of their use in a schedule for pediatric prophylactic inoculations].
    Gorbunov MA; Pavlova LI; Titov IA; Bektimirov TA; Selezneva VP; Shitikova OIu; Mamontova TV; Indikova IN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):55-8. PubMed ID: 9460867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in healthy adolescents on two-dose schedule.
    Chen CC; Chang MH; Lee HC; Twu SJ; Safary A
    Acta Paediatr Taiwan; 1999; 40(3):157-60. PubMed ID: 10910606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The long-term efficacy of a recombinant hepatitis B vaccine in newborns].
    Tejedor Torres JC; Reyes Pecharromán S; Pérez Rivilla A; Sayalero Martín M; Aybar Garciá L; Sánchez de León L; Puyol Buil P
    An Esp Pediatr; 1993 Sep; 39(3):243-7. PubMed ID: 8250440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel].
    Ricciardi G; Graziano G
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):385-90. PubMed ID: 2152297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies.
    Greenberg DP
    Pediatr Infect Dis J; 1993 May; 12(5):438-45. PubMed ID: 8327313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and efficacy of a recombinant DNA hepatitis B vaccine, GenHevac B Pasteur in high risk neonates, school children and healthy adults.
    Assateerawatt A; Tanphaichitr VS; Suvatte V; Yodthong S
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):85-91. PubMed ID: 8216564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
    Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F;
    Lancet Infect Dis; 2015 Nov; 15(11):1283-91. PubMed ID: 26257021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
    Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
    J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults.
    Rustgi VK; Schleupner CJ; Krause DS
    Vaccine; 1995 Dec; 13(17):1665-8. PubMed ID: 8719517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroconversion with rDNA hepatitis B vaccine of Cuban origin.
    Kar P; Jandwani P; Khurana V; Kumar V; Gupta RK; Sama S; Wadhawan S
    Indian J Gastroenterol; 1997 Oct; 16(4):161. PubMed ID: 9357198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.
    Schiff GM; Sherwood JR; Zeldis JB; Krause DS
    J Adolesc Health; 1995 Jan; 16(1):12-7. PubMed ID: 7742331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against hepatitis B virus in children and adolescents in a pediatric hospital.
    Catania G; Di Ciommo V; Concato C
    Recenti Prog Med; 1996 Jun; 87(6):271-4. PubMed ID: 8766952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.